Filing Details
- Accession Number:
- 0001144204-15-016837
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-17 19:29:53
- Reporting Period:
- 2015-03-17
- Filing Date:
- 2015-03-17
- Accepted Time:
- 2015-03-17 19:29:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
727207 | Accelerate Diagnostics Inc | AXDX | Laboratory Analytical Instruments (3826) | 841072256 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1388833 | Lawrence Mehren | 5661 North Calle Mayapan Tucson AZ 85718 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-17 | 500 | $20.48 | 500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,576,792 | Indirect | Through MAB, LLC |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at various prices. The reporting person undertakes to provide Accelerate Diagnostics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- The reporting person is the manager of MAB, LLC and in that capacity has sole voting and dispositive power with respect to the shares held by it. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.